title: Malignant peritoneal mesothelioma. Is there a new treatment?
abstract: The authors report a novel, alternative approach to treat malignant peritoneal mesothelioma (MPeM) targeting, vascular endothelial growth factor (VEGF) using anti-VEGF (bevacizumab) chemotherapy combination.
authors.affiliation: Al-Amal Hospital, Hamad Medical Corporation/Doha, Qatar;
authors.forename: Kakil Ibrahim
authors.initials: KI
authors.lastname: Rasul
authors.forename: David J
authors.initials: DJ
authors.lastname: Kerr